PHARMACOGENOMIC DRUG INTERACTION
Clinical trials for PHARMACOGENOMIC DRUG INTERACTION explained in plain language.
Never miss a new study
Get alerted when new PHARMACOGENOMIC DRUG INTERACTION trials appear
Sign up with your email to follow new studies for PHARMACOGENOMIC DRUG INTERACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can your genes guide better depression treatment? new trial aims to find out.
Disease control Not yet recruitingThis study will test whether having a pharmacist review a patient's genetic test results can improve treatment for major depression. 220 adults in Pennsylvania who are starting or changing antidepressant medication will be randomly assigned to either receive this specialized medi…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can your DNA predict how you respond to a diabetes drug?
Knowledge-focused Not yet recruitingThis study investigates how different genetic pathways affect the body's response to food and to a short course of orforglipron, an oral GLP-1 drug used for weight management and blood sugar control. Researchers will enroll about 100 adults, with or without type 2 diabetes, who a…
Matched conditions: PHARMACOGENOMIC DRUG INTERACTION
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC